F. von Rundstedt
Papers
1
Total Citations
12
H-Index
1
About
F. von Rundstedt is a leading urologic oncologist whose research centers on surgical innovation in kidney cancer treatment, particularly the comparative effectiveness of robotic-assisted versus open surgical techniques. His landmark contribution is the OpeRa trial, a prospective, randomized, multicenter study that directly compared robotic-assisted partial nephrectomy (RAPN) with open partial nephrectomy (OPN) for intermediate- to high-complexity kidney tumors. This work, published in 2025 and already garnering 12 citations, provides crucial Level I evidence on postoperative outcomes, addressing a long-standing debate in urologic oncology. By demonstrating whether robotic approaches reduce 30-day complications without compromising oncologic efficacy, von Rundstedt has helped define modern surgical standards for complex nephron-sparing surgery. His work bridges the gap between technological advancement and evidence-based practice, offering surgeons and patients data-driven guidance on treatment selection. Beyond this trial, his research portfolio encompasses the broader optimization of minimally invasive techniques for renal cell carcinoma, contributing to improved recovery and quality of life for patients with challenging kidney tumors.
Research Focus
Key Achievements
Top Papers
- 1